← OptimizeRx Corp
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | ($1.5m) | ($2.1m) | $226k | ($3.1m) | ($2.2m) | $378k | ($11.4m) | ($17.6m) | ($20.1m) | $5.1m | — | |
| Depreciation, Depletion and Amortization | $235k | $325k | $317k | $1.3m | $2.1m | $2.1m | $2.0m | $2.4m | $4.3m | $4.3m | $4.3m | |
| Amortization | — | — | $258k | $1.1m | $1.9m | $1.9m | — | — | — | — | $4.2m | |
| Amortization of Debt Issuance Costs | — | — | — | — | — | — | — | $211k | $835k | $1.1m | — | |
| Amortization of Intangible Assets | — | — | — | — | — | — | — | — | $4.2m | $4.2m | — | |
| Capitalized Computer Software, Amortization | $153k | $208k | — | — | — | — | — | — | — | — | — | |
| Depreciation | $22k | $49k | $58k | $80k | $95k | $105k | $86k | $100k | $111k | $102k | $102k | |
| Deferred Income Tax Expense (Benefit) | — | — | — | — | — | — | — | $1.2m | $153k | $1.2m | — | |
| Share-based Payment Arrangement, Noncash Expense | $175k | $87k | $1.9m | $2.3m | $3.2m | — | $15.7m | $13.7m | $11.5m | $7.0m | $7.2m | |
| Payment, Tax Withholding, Share-based Payment Arrangement | — | — | — | — | — | — | — | — | $911k | — | — | |
| Share-based Payment Arrangement, Expense | $559k | $902k | $2.5m | $2.3m | $3.2m | $5.5m | $15.7m | — | — | $7.0m | $7.2m | |
| Share-based Payment Arrangement, Expensed and Capitalized, Amount | — | $815k | $1.3m | — | — | — | — | — | — | — | $7.2m | |
| Goodwill, Impairment Loss | — | — | — | — | — | — | — | — | — | $0 | $7.6m | |
| Impairment of Intangible Assets (Excluding Goodwill) | — | — | — | — | — | — | — | — | — | $368k | — | |
| Nonoperating Income (Expense) | $42k | $26k | $46k | — | — | — | — | $1.2m | ($5.7m) | ($4.7m) | — | |
| Other Nonoperating Income (Expense) | — | — | — | ($347k) | ($72k) | $17k | $852k | — | — | — | — | |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts Receivable | $213k | $305k | $2.8m | $629k | $10.7m | $7.0m | ($2.3m) | $8.7m | $2.2m | ($460k) | $731k | |
| Increase (Decrease) in Accounts Payable | ($206k) | $88k | ($83k) | ($46k) | — | ($11k) | $943k | ($1.3m) | ($72k) | ($520k) | ($1.1m) | |
| Gain (Loss) on Disposition of Other Assets | — | — | — | — | — | — | — | ($2.1m) | — | — | — | |
| Net Cash Provided by (Used in) Operating Activities | ($466k) |
($1.5m)
-217.58%
|
$793k
+153.56%
|
($1.7m)
-309.55%
|
($6.3m)
-279.96%
|
$726k
+111.51%
|
$10.7m
+1367.43%
|
($7.2m)
-167.95%
|
$4.9m
+167.54%
|
$18.7m
+282.80%
|
$14.4m
-23.14%
|
|
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Property, Plant, and Equipment | $178k | $42k | $34k | $88k | $68k | $100k | $81k | $87k | $112k | $58k | ($340k) | |
| Gain (Loss) on Disposition of Property Plant Equipment | — | — | — | — | — | — | — | ($1.3m) | — | — | $2.1m | |
| Unrealized Gain (Loss) on Investments | — | — | — | — | — | $19.1m | $35.1m | $12.3m | — | — | — | |
| Payments to Acquire Businesses, Net of Cash Acquired | — | — | $5.6m | $9.0m | — | — | $2.0m | $82.9m | — | — | $0 | |
| Net Cash Provided by (Used in) Investing Activities | ($350k) | ($42k) | ($5.7m) | ($10.6m) | ($125k) | ($486k) | ($58.2m) | ($25.3m) | ($450k) | $68k | $131k | |
| Cash flows from financing activities: | ||||||||||||
| Repayments of Long-term Debt | — | — | — | — | — | — | — | $1.7m | $4.0m | $8.0m | ($10.2m) | |
| Payments for Repurchase of Common Stock | — | $390k | — | — | — | — | $20.0m | $7.5m | — | — | — | |
| Proceeds from Issuance of Common Stock | $450k | — | $8.2m | $21.3m | — | $70.7m | — | — | — | — | — | |
| Net Cash Provided by (Used in) Financing Activities | ($357k) |
($390k)
-9.12%
|
$8.7m
+2327.11%
|
$22.2m
+155.38%
|
($1.9m)
-108.57%
|
$73.9m
+3989.16%
|
($19.0m)
-125.64%
|
$28.2m
+248.91%
|
($4.9m)
-117.40%
|
($8.8m)
-79.15%
|
($10.9m)
-24.11%
|
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | ($1.9m) | $3.8m | $9.9m | ($8.3m) | $74.2m | ($66.5m) | ($4.4m) | ($472k) | $10.0m | $20.2m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | — | — | — | $84.7m | $18.2m | $13.9m | $13.4m | $23.4m | $20.2m | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | — | — | — | — | — | — | — | $1.2m | $6.2m | $4.2m | — | |
| Income Taxes Paid, Net | — | — | — | $898k | — | $4.9m | $1.1m | $48k | $161k | $1.8m | — | |
| Additional Financial Items | ||||||||||||
| Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal | — | — | — | — | — | — | — | ($2.1m) | — | — | — | |
| Financing Interest Expense | — | — | — | — | — | — | — | $5.0m | — | — | — | |
| Gain (Loss) on Disposition of Assets | $0 | ($66k) | ($2k) | — | — | — | — | — | — | — | — | |
| Goodwill | — | — | $3.7m | $14.7m | $14.7m | $14.7m | $22.7m | $78.4m | $70.9m | $70.9m | $7.6m | |
| Income Tax Expense (Benefit) | — | — | — | ($898k) | — | — | — | ($7.6m) | $725k | $1.8m | — | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | — | $6.2m | $5.3m | — | |
| Investment Income, Interest | — | $26k | $46k | $288k | $69k | $17k | — | $2.2m | $329k | $353k | — | |
| Operating Expenses | $5.9m | $8.1m | $12.0m | $19.1m | $26.2m | $35.3m | $51.3m | $69.3m | $73.1m | $61.9m | — | |
| Proceeds from Stock Options Exercised | — | — | $521k | $878k | $2.5m | $4.9m | $1.1m | $278k | $0 | $352k | — | |
| Stock or Unit Option Plan Expense | — | — | $1.4m | $1.6m | $1.8m | $9.7m | $12.5m | $9.0m | — | — | — |